Datasets
Buyer room
TRANSDATANEXUS.COMManage supplier listing
TransDataNexus — Resolved US healthcare and pharmaceutical intelligence layer built on a single canonical molecule key: 177 catalogued datasets on a Data Atlas spanning 1939 to 2028, 323.9 million curated records counted from the records themselves, tracking $2.21 trillion of drug spend across paid registers. Integrated content includes spending, prescribers, approvals, patents, manufacturing plants (a plant map of 9,015 facilities), payer plans, shipments, coverage and restrictions, channel mix, pricing and IRA selection risk, market share, pipeline and promotional spend, inspection citation…
supplier index read from their site
Resolved US healthcare and pharmaceutical intelligence layer built on a single canonical molecule key: 177 catalogued datasets on a Data Atlas spanning 1939 to 2028, 323.9 million curated records counted from the records themselves, tracking $2.21 trillion of drug spend across paid registers. Integrated content includes spending, prescribers, approvals, patents, manufacturing plants (a plant map of 9,015 facilities), payer plans, shipments, coverage and restrictions, channel mix, pricing and IRA selection risk, market share, pipeline and promotional spend, inspection citations and demand by molecule. Every figure carries source-register and vintage lineage, overlapping registers are reconciled by maximum rather than sum to prevent double counting, and the whole layer is read-only. A separate pharma Trade Intelligence layer covers global export/import shipments, exporters, buyers and prices across 180+ countries.
From 87 yearsCoverage Health CareAsset class Equities
Sample, licence terms, pricing and eval results when TransDataNexus publishes them. Until then, discover alternatives today with a 7-day trial.
Start 7-day trial →What buyers ask about TransDataNexus, answered from this page.
TransDataNexus — Resolved US healthcare and pharmaceutical intelligence layer built on a single canonical molecule key: 177 catalogued datasets on a Data Atlas spanning 1939 to 2028, 323.9 million curated records counted from the records themselves, tracking $2.21 trillion of drug spend across paid registers. Integrated content includes spending, prescribers, approvals, patents, manufacturing plants (a plant map of 9,015 facilities), payer plans, shipments, coverage and restrictions, channel mix, pricing and IRA selection risk, market share, pipeline and promotional spend, inspection citation…
TransDataNexus offers (Alternative, Fundamental, Reference, Supply Chain) — Vendor-stated: 323.9 million curated records across 177 datasets, $2.21 trillion of tracked drug spend, a 9,015-plant map, and a 1939-2028 vintage window. The adjacent trade layer is separately stated at tens of millions of shipment records, 3.7 million shipments / 81k+ companies / 7,900+ drugs in one framing, and 93 data sources resolved into a linked graph described by the founder as 15+ billion linked data points..
Gross-to-net and net-spend benchmarking by molecule with lineage and vintage; generic and biosimilar entry timing and queued-competitor models; API and finished-dose supply-risk and sourcing optimisation using the plant-inspection graph; IRA/Medicare price-selection risk screening; market-access and formulary-restriction modelling; competitive-share and promotional-spend elasticity models; pharma procurement cost modelling and total-cost-of-ownership analysis; training entity-resolution models on the molecule-key crosswalk (the hardest reusable artefact here); natural-language-to-SQL training pairs from the Ask console over a real regulated schema
The data is with 87 years of history.
Coverage spans US, APAC, UK; Pharmaceuticals, Health Care Technology; alternative, fundamental, reference, supply_chain; equities.
TransDataNexus has not added their own details yet. Not yet on file: